Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Hepatitis and Australia antigen: autosomal recessive inheritance of susceptibility to infection in humans.

Blumberg BS, Friedlaender JS, Woodside A, Sutnick AI, London WT.

Proc Natl Acad Sci U S A. 1969 Apr;62(4):1108-15.

2.

The nature of australia antigen and its relation to antigen-antibody complex formation.

Blumberg BS, Millman I, Sutnick AI, London WT.

J Exp Med. 1971 Sep 1;134(3):320-9.

4.

Characterization of a precipitating antigen detected in the serum of patients with viral hepatitis.

Zhuang H, Coulepis AG, Locarnini SA, Kaldor J, Marshall JA, Gust ID.

J Med Virol. 1983;11(4):267-76.

PMID:
6409994
5.

Preparation and standardization of an Australia antigen antibody of equine origin.

Cabasso VJ, Nieman R, Schroeder DD, Hok KA, Louie RE, Mozen MM.

Appl Microbiol. 1971 Jun;21(6):1017-23.

7.
9.

Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection.

Ramezani A, Hasanjani Roshan MR, Kalantar E, Eslamifar A, Banifazl M, Taeb J, Aghakhani A, Gachkar L, Velayati AA.

J Gastroenterol Hepatol. 2008 Nov;23(11):1716-21. doi: 10.1111/j.1440-1746.2008.05482.x. Epub 2008 Aug 28.

PMID:
18761557
10.

T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection.

Ito K, Tanaka Y, Orito E, Sugiyama M, Fujiwara K, Sugauchi F, Kato T, Tokita H, Izumi N, Kato M, Yuen MF, Lai CL, Gish RG, Ueda R, Mizokami M.

Clin Infect Dis. 2006 Jan 1;42(1):1-7. Epub 2005 Nov 29.

PMID:
16323084
11.

Alport syndrome. Molecular genetic aspects.

Hertz JM.

Dan Med Bull. 2009 Aug;56(3):105-52.

PMID:
19728970
12.

Preliminary observations on Au-anti-Au immune complex research by a modified electrosyneresis method.

Bedarida G, Zacchi T, Tassi GC.

Boll Ist Sieroter Milan. 1971 Mar-Apr;50(2):74-82. No abstract available.

PMID:
5004394
13.

[Natural history of hepatitis B virus infection in dialysis patients: prospective study by quantitative analysis of HBV viremia].

Fabrizi F, Lunghi G, Finazzi S, Colucci P, Pagliari B, Bisegna S, Tettamanzi F, Ponticelli C.

G Ital Nefrol. 2002 May-Jun;19(3):294-300. Italian.

PMID:
12195397
14.

Comparison of three serological methods for the detection of hepatitis-associated antigen.

White GB, Lasheen RM, Baillie MB, Turner GC.

J Clin Pathol. 1971 Feb;24(1):8-12.

16.

Evidence for HLA-linked susceptibility factors in childhood leukemia.

Von Fliedner VE, Merica H, Jeannet M, Barras C, Feldges A, Imbach P, Wyss M.

Hum Immunol. 1983 Nov;8(3):183-93.

PMID:
6417071
17.

[Clinical and virological evaluation of the detection of pre-S1 and pre-S2 antigens in serum from patients with chronic hepatitis B].

Zoulim F, Capel F, Berthillon P, Trépo C, Petit MA.

Gastroenterol Clin Biol. 1995 Dec;19(12):970-5. French.

PMID:
8729407
18.

HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection?

Peano G, Menardi G, Ponzetto A, Fenoglio LM.

Arch Intern Med. 1994 Dec 12-26;154(23):2733-6.

PMID:
7993158
19.

Role of the bovine immune system and genome in resistance to gastrointestinal nematodes.

Gasbarre LC, Leighton EA, Sonstegard T.

Vet Parasitol. 2001 Jul 12;98(1-3):51-64. Review.

PMID:
11516579
20.

HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.

Momosaki S, Nakashima Y, Kojiro M, Tabor E.

J Viral Hepat. 2005 May;12(3):325-9.

PMID:
15850475

Supplemental Content

Support Center